Immunologic adverse reactions of β-blockers and the skin (Review)

作者: Alin Tatu , Alina Elisei , Valentin Chioncel , Magdalena Miulescu , Lawrence Nwabudike

DOI: 10.3892/ETM.2019.7504

关键词:

摘要: β-Blockers are a widely utilised class of medication. They have been in use for variety systemic disorders including hypertension, heart failure and intention tremors. Their dermatology has garnered growing interest with the discovery their therapeutic effects treatment haemangiomas, potential positive wound healing, Kaposi sarcoma, melanoma pyogenic granuloma, and, more recently, pemphigus. Since β-blockers deployed disorders, which cutaneous co-morbidities such as psoriasis, pertinence to dermatologists cannot be overstated. Likewise, β-blockers, like any other drug category, carry risks side effects, some dermatologic. These include triggering exacerbation psoriatic rheumatoid arthritis, anaphylaxis, contact dermatitis, occupational Raynaud's disease, alopecia, lichen planus-like eruption, hyperhydrosis vitiligo. While recent articles focussed on uses it may also wise call our attention dermatologic adverse that follow β-blocker use, well possible approaches these. This short review will focus those dermatoses resulting from an immunologic basis.

参考文章(60)
John Koo, Meghan O'Brien, The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. Journal of Drugs in Dermatology. ,vol. 5, pp. 426- 432 ,(2006)
J D England, J R England, Alopecia and propranolol therapy. Australian Family Physician. ,vol. 11, pp. 225- 226 ,(1982)
R J Hilder, Propranolol and alopecia. Cutis. ,vol. 24, pp. 63- 64 ,(1979)
Faisal Ali, David Shackleton, Timothy Kingston, Jason Williams, Occupational exposure to propranolol: A rarely recognised cause of allergic contact dermatitis International Journal of Occupational Medicine and Environmental Health. ,vol. 28, pp. 639- 640 ,(2015) , 10.13075/IJOMEH.1896.00429
Nikolai Tsankov, Irena Angelova, Jana Kazandjieva, Drug-Induced Psoriasis American Journal of Clinical Dermatology. ,vol. 1, pp. 159- 165 ,(2000) , 10.2165/00128071-200001030-00003
James Q Del Rosso, Grace K Kim, Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated?: Understanding Pathophysiology and Clinical Relevance The Journal of clinical and aesthetic dermatology. ,vol. 3, pp. 32- 38 ,(2010)
Mohammad S. Alorainy, Shahid Akbar, The current status of beta blockers' use in the management of hypertension. Saudi Medical Journal. ,vol. 35, pp. 1307- 1317 ,(2014)
Denise Lage, Priscila Bianchini Juliano, Konradin Metze, Elemir Macedo de Souza, Maria Letícia Cintra, Lichen planus and lichenoid drug‐induced eruption: a histological and immunohistochemical study International Journal of Dermatology. ,vol. 51, pp. 1199- 1205 ,(2012) , 10.1111/J.1365-4632.2011.05113.X
S. Halevy, E. Livni, Psoriasis and psoriasiform eruptions associated with propranolol — the role of an immunological mechanism Archives of Dermatological Research. ,vol. 283, pp. 472- 473 ,(1991) , 10.1007/BF00371785
Shawn Richards, CUTANEOUS SIDE‐EFFECTS OF BETA‐ADRENERGIC BLOCKERS Australasian Journal of Dermatology. ,vol. 26, pp. 25- 28 ,(1985) , 10.1111/J.1440-0960.1985.TB01810.X